β-catenin, a vital multifunctional protein, plays a crucial role in maintaining physiological balance. Abnormal overexpression of β-catenin leads to various diseases, including cancer. In humans, the analogous gene to drosophila's armadillo is β-catenin, which serves as both an adapter protein for cell adhesion and a co-regulator of gene transcription.
The beta-catenin market is anticipated to experience growth due to an increase in the occurrence of genetic disorders. Similarly, market growth is expected to be driven by the rise in the approval of gene therapy drugs during the forecast period.
The projected worth of the global Beta-Catenin Market in 2022 is approximately US$ 2,492.0 million, with an anticipated compound annual growth rate (CAGR) of 9.6% from 2022 to 2030.
key Companies in the Beta-Catenin Industry:
- Boston Biomedical, Inc.
Boston Biomedical Inc. was established in 2006 and is headquartered in Cambridge, Massachusetts, U.S. It is engaged in various industries, including biotechnology, healthcare, medical, and therapeutics.
- Dicerna Pharmaceuticals, Inc.
Dicerna Pharmaceuticals Inc. was established in 2006 and is headquartered in Lexington, Massachusetts, U.S. It is engaged in various industries, including biotechnology, healthcare, genetics, and pharmaceuticals.
- Marina Biotech, Inc.
Marina Biotech Inc. was established in 1983 and is headquartered in California, U.S. It is engaged in various industries, including biotechnology, healthcare, medical, and pharmaceuticals.
- Propanac Biopharma, Inc.
Propanac Biopharma Inc. was established in 2007 and is headquartered in Australia. It operates as a clinical-stage biopharmaceutical company and is engaged in various industries, including biotechnology, healthcare, and health diagnostics.
- Warp Drive Bio, Inc.
Warp Drive Bio, Inc. was established in 2010 and is headquartered in Cambridge, Massachusetts, U.S. It is engaged in various industries, including biotechnology, genetics, natural resources, and developing search engines.
- Aileron Therapeutics, Inc.
Aileron Therapeutics Inc. was established in 2001 and is headquartered in Cambridge, Massachusetts, U.S. It is engaged in various industries, including biopharmaceuticals, biotechnology, and therapeutics.
- Sapience Therapeutics, Inc.
Sapience Therapeutics Inc. was established in 2015 and is headquartered in Scarsdale, New York, U.S. It is engaged in various industries, including biotechnology, medical, and therapeutics.
- MD2 Biosciences, Inc.
MD2 Biosciences Inc. was established in 2015 and is headquartered in San Diego, U.S. It is engaged in developing a first-in-class oncogenic-specific Wnt pathway inhibitor for colorectal cancer patients.
Definition: Beta-catenin is a protein involved in cell signaling and development, regulating gene expression and cell adhesion.
